The financial success of an overseas company/individual, including its wealth surpassing tycoons like Li Ka-shing, is drawing the attention of financial investigators, including the SEC in Bangladesh.
1 report, 0 independent
Updated Jun 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The financial success of an overseas company/individual, including its wealth surpassing tycoons like Li Ka-shing, is drawing the attention of financial investigators, including the SEC in Bangladesh.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Regencell Bioscience
traditional Chinese herbal treatment company
- Regencell Bioscience Holdings Limited began trading on the electronic stock exchange on June 1, 2026, while facing a lawsuit invoking federal securities laws.
- Diageo is offering American-Made Foreign Liquor whiskies, RBB Bancorp serves Asian-American communities, and Regencell operates a Traditional Chinese medicine company.
-
Securities and Exchange Commission (Bangladesh)
government regulatory body overseeing the stock market
-
Hong Kong
city and special administrative region of China
Coverage
Newest first; wire copies grouped- Unknown outlet